Skip to main content
OpenTrials
Completed

NCT Number: NCT05606783

Using Bluetooth Home Blood Pressure Monitors With Pharmacist Interventions

Family Medicine patients with uncontrolled hypertension will be given a Bluetooth enabled home blood pressure machine to monitor their blood pressure every day for 6 weeks. The blood pressure results will be sent automatically to the patient's electronic medical record via applications on their iPhone. Study pharmacists will follow-up with the patients once per week via a telehealth appointment using the app VSee, where the blood pressure results will be reviewed. The pharmacists will also counsel the patients on lifestyle modifications in order to improve blood pressure.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hypertension Cardiovascular Diseases Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

USF Pharmacy Plus

Tampa, Florida, 33612, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • must be at least 18 years old
  • have a smartphone compatible with the mobile intervention (iPhone)
  • have been previously diagnosed with hypertension
  • have uncontrolled hypertension (SBP > 130 mmHg and/or DBP > 80 mmHg)
  • be under the care of a primary care physician in the Family Medicine Department of the USF Morsani Center for Advanced Care
  • have had at least one prescription filled at Pharmacy Plus within the last six months
  • speaks English fluently

Exclusion criteria

  • already under the care of a clinical pharmacist in the Family Medicine department
  • pregnant
  • have a serious existing medical condition(s) that may affect their ability to self-monitor their blood pressure (for example, stroke, dementia)

Treatment and study plan

Telehealth Follow-up Visits

Behavioral
  • Follow-up with patients once per week for six (6) weeks via scheduled 20-minute telehealth appointment with each patient via the HIPAA secure and compliant platform, VSee

o During this telehealth appointment, the study pharmacists will counsel the patients on their blood pressure readings for that week and provide lifestyle education focusing on patient-specific diet and exercise recommendations

Surveys

Behavioral

A pre- and post-survey will be given at the initial and final in-person appointments, respectively

  • These surveys will collect basic patient demographics, knowledge of blood pressure, comfort with checking blood pressure at home, and previous experience working with a pharmacist

Devices

Device

Smart Phones with Apple Health Software will be used to monitor blood pressure once a day, and results will be sent automatically to the patients EHR (Epic)

  • The Omron 10 Series Wireless Upper Arm Blood Pressure Device will be given to the patient to monitor blood pressure at home daily

Primary outcomes

  1. Comfort

    Time frame: 8 weeks

    Patient comfort in using home telemonitoring for blood pressure combined with pharmacist counseling and monitoring will be measured using a survey instrument with a Likert scale (4-point scale). (Most of the time; Some of the time; Seldom; Never) (Strongly agree; Agree; Disagree; Strongly disagree) (Nothing; Very little; Some; Knowledgeable)

Secondary outcomes

  1. Determine if pharmacists' interventions improved BP

    Time frame: 8 weeks

    BP readings were reported and evaluated to discover if these were improved with pharmacists' interventions.

Sponsors and collaborators

Lead sponsor

University of South Florida

Other

Collaborators

  • National Association of Chain Drug Stores

Registry information

Official study title

Using Bluetooth Home Blood Pressure Monitors With Pharmacist Interventions to Manage Uncontrolled Hypertension in the Community Setting - A Pilot Study

Important dates

Study start
2019
Primary completion
2019
Study completion
2019
First posted
Nov 7, 2022
Registry last updated
Nov 7, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.